GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthEquity Inc (NAS:HQY) » Definitions » Cash Flow from Investing

HealthEquity (HealthEquity) Cash Flow from Investing : $-46.1 Mil (TTM As of Jan. 2024)


View and export this data going back to 2014. Start your Free Trial

What is HealthEquity Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the three months ended in Jan. 2024, HealthEquity spent $0.6 Mil on purchasing property, plant, equipment. It gained $0.0 Mil from selling property, plant, and equipment. It spent $0.0 Mil on purchasing business. It gained $0.0 Mil from selling business. It spent $0.0 Mil on purchasing investments. It gained $0.0 Mil from selling investments. It paid $10.7Mil for net Intangibles purchase and sale. And it received $0.0 Mil from other investing activities. In all, HealthEquity spent $11.3 Mil on investment activities in financial market and operating subsidiaries for the three months ended in Jan. 2024.


HealthEquity Cash Flow from Investing Historical Data

The historical data trend for HealthEquity's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HealthEquity Cash Flow from Investing Chart

HealthEquity Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,740.49 -96.96 -639.25 -119.13 -46.07

HealthEquity Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.28 -9.14 -10.25 -15.42 -11.27

HealthEquity Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

HealthEquity's Cash Flow from Investing for the fiscal year that ended in Jan. 2024 is calculated as:

HealthEquity's Cash Flow from Investing for the quarter that ended in Jan. 2024 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-46.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HealthEquity  (NAS:HQY) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

HealthEquity's purchase of property, plant, equipment for the three months ended in Jan. 2024 was $-0.6 Mil. It means HealthEquity spent $0.6 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

HealthEquity's sale of property, plant, equipment for the three months ended in Jan. 2024 was $0.0 Mil. It means HealthEquity gained $0.0 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

HealthEquity's purchase of business for the three months ended in Jan. 2024 was $0.0 Mil. It means HealthEquity spent $0.0 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

HealthEquity's sale of business for the three months ended in Jan. 2024 was $0.0 Mil. It means HealthEquity gained $0.0 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

HealthEquity's purchase of investment for the three months ended in Jan. 2024 was $0.0 Mil. It means HealthEquity spent {stock_data.stock.currency_symbol}}0.0 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

HealthEquity's sale of investment for the three months ended in Jan. 2024 was $0.0 Mil. It means HealthEquity gained $0.0 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

HealthEquity's net Intangibles purchase and sale for the three months ended in Jan. 2024 was $-10.7 Mil. It means HealthEquity paid $10.7 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

HealthEquity's cash from discontinued investing activities for the three months ended in Jan. 2024 was 0.0 Mil. It means HealthEquity paid $0.0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

HealthEquity's cash from other investing activities for the three months ended in Jan. 2024 was $0.0 Mil. It means HealthEquity received $0.0 Mil from other investing activities.


HealthEquity Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of HealthEquity's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


HealthEquity (HealthEquity) Business Description

Traded in Other Exchanges
Address
15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. Its technology allows customers to see their tax-advantaged healthcare savings, compare treatment options and pricing, pay healthcare bills, receive benefit information, and earn wellness incentives. The firm primarily partners with health plans and employers and serves as the custodian of its customers' health savings accounts (HSAs). HealthEquity also engages in reimbursement arrangements and offers healthcare incentives to its members. In addition, the company provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Executives
Delano Ladd officer: Executive VP, GC & Corp. Secy. 15W. SCENIC POINTE DR., SUITE 100, DRAPER UT 84020
Ian Sacks director TOWERBROOK CAP., PARK AVENUE TOWER, 65 E 55TH ST., 27TH FLOOR, NEW YORK NY 10022
Elimelech Rosner officer: EVP, Chief Technology Officer 5196 BELMORE COURT, SUWANEE GA 30024
Stephen Neeleman director, officer: Founder and Vice Chairman 15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Tyson D. Murdock officer: EVP & CFO 2275 S. 2200 E., SALT LAKE CITY UT 84109
Jon Kessler director, officer: President and CEO 15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Frank Corvino director GREENWICH HOSPITAL, 5 PERRYRIDGE ROAD, GREENWICH CT 06830
Larry L Trittschuh officer: EVP Chief Security Officer 1051 RUNNYMEDE ROAD, OAKWOOD OH 45419
James M Lucania officer: EVP & CFO 101 WOLF DRIVE, THOROFARE NJ 08086
Gayle Furgurson Wellborn director 123 TORRENCE CHAPEL ROAD, MOORESVILLE NC 28117
Debra Charlotte Mccowan director 1436 CABRILLO AVENUE, BURLINGAME CA 94010
Paul Black director 400 WOOD ROAD, BRAINTREE MA 02184
Edward Bloomberg officer: Chief Operating Officer 13207 WINDSOR STREET, LEAWOOD KS 66209
Rajesh Natarajan director 7500 DALLAS PARKWAY, SUITE 700, PLANO TX 75024
Evelyn S Dilsaver director C/O LONGS DRUG STORES CORPORATION, 141 NORTH CIVIC DRIVE, WALNUT CREEK CA 94596